2.47

2.47 (0.11%)

As of Apr 16, 2021

Akers Biosciences, Inc. [AKER]

Source: 

Company Overview

MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan. MyMD is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets, MYMD-1 and Supera-CBD

CountryUS
Headquartersbaltimoremaryland
Phone Number(856) 848-8698
Industryin vitro & in vivo diagnostic substances
CEOChristopher C. Chapman, M.D.
Websitemymd.com

Recent Stories